This document summarizes a presentation on synthetic cannabinoids and other emerging drugs of abuse. It discusses how synthetic cannabinoids like Spice, K2, and bath salts are sold as herbal incense products but actually contain potent synthetic cannabinoid chemicals. It describes the effects of these drugs and challenges around detecting and regulating them. The presentation also covers natural drugs like cannabis and kratom, and discusses drug development related to cannabinoid receptors.
Pharmacodynamics and Pharmacokinetics of Synthetic CannabinoidsNMS Labs
Presented on February 21, 2012 at the AAFS 64th Annual Scientific Meeting by Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services and Wendy R. Adams, Ph.D., DABFT, Forensic Toxicologist
K2 and the Synthetic Cannabinoids: Pharmacology, Effects and Chemical AnalysisNMS Labs
The document discusses K2 and synthetic cannabinoids like JWH-018 and JWH-073. It summarizes their origins, effects, and challenges in analyzing them. Studies found synthetic cannabinoids can cause effects like tachycardia, dry mouth, impaired coordination and concentration. They are difficult to detect but studies found metabolites in blood and urine for hours after use, requiring targeted analysis to identify them in overdose or DUI cases.
Cannabis Chemistry Industrial Applications of Chemistry & Innovation and Entr...Markus Roggen
Lecture at the chemistry department of Imperial College, London. A brought overview and specific deep dive into the chemical aspects of cannabis production.
CBDV is a research venture seeking to develop analytical methods like HPLC to quantify psilocybin in psychedelic mushrooms for cultivation sites, as current methods take too long; they developed a 3.5 minute HPLC method using ammonium bicarbonate and acetonitrile to quantify psilocybin without degradation, and will next explore extraction methods from mushrooms.
This document summarizes information from a presentation on cannabis extraction. It discusses defining extracts and what constitutes an extract in terms of cannabis compounds. It also examines optimizing extraction processes by exploring factors like temperature, pressure, time and their effects on yield, cannabinoid concentration and terpene content. The document compares subcritical and supercritical extraction methods and shares lessons learned from experiments. It also briefly discusses other separation techniques like rosin presses and ice water hash.
CannMed 2018: Controlling Terpenes and Cannabinoids in Flower and ExtractMarkus Roggen
This document summarizes a presentation about controlling terpenes and cannabinoids in cannabis flowers and extracts. It discusses how cultivation conditions, drying/curing methods, extraction techniques, and post-processing can influence terpene and cannabinoid levels and ratios. It provides an example of how using THC from different cultivars in a CBD/THC oil caused a patient's seizures to resume, demonstrating the importance of chemovars for medical effects. The presenter advocates for research collaborations to better understand these complex relationships.
This document summarizes a presentation on synthetic cannabinoids and other emerging drugs of abuse. It discusses how synthetic cannabinoids like Spice, K2, and bath salts are sold as herbal incense products but actually contain potent synthetic cannabinoid chemicals. It describes the effects of these drugs and challenges around detecting and regulating them. The presentation also covers natural drugs like cannabis and kratom, and discusses drug development related to cannabinoid receptors.
Pharmacodynamics and Pharmacokinetics of Synthetic CannabinoidsNMS Labs
Presented on February 21, 2012 at the AAFS 64th Annual Scientific Meeting by Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services and Wendy R. Adams, Ph.D., DABFT, Forensic Toxicologist
K2 and the Synthetic Cannabinoids: Pharmacology, Effects and Chemical AnalysisNMS Labs
The document discusses K2 and synthetic cannabinoids like JWH-018 and JWH-073. It summarizes their origins, effects, and challenges in analyzing them. Studies found synthetic cannabinoids can cause effects like tachycardia, dry mouth, impaired coordination and concentration. They are difficult to detect but studies found metabolites in blood and urine for hours after use, requiring targeted analysis to identify them in overdose or DUI cases.
Cannabis Chemistry Industrial Applications of Chemistry & Innovation and Entr...Markus Roggen
Lecture at the chemistry department of Imperial College, London. A brought overview and specific deep dive into the chemical aspects of cannabis production.
CBDV is a research venture seeking to develop analytical methods like HPLC to quantify psilocybin in psychedelic mushrooms for cultivation sites, as current methods take too long; they developed a 3.5 minute HPLC method using ammonium bicarbonate and acetonitrile to quantify psilocybin without degradation, and will next explore extraction methods from mushrooms.
This document summarizes information from a presentation on cannabis extraction. It discusses defining extracts and what constitutes an extract in terms of cannabis compounds. It also examines optimizing extraction processes by exploring factors like temperature, pressure, time and their effects on yield, cannabinoid concentration and terpene content. The document compares subcritical and supercritical extraction methods and shares lessons learned from experiments. It also briefly discusses other separation techniques like rosin presses and ice water hash.
CannMed 2018: Controlling Terpenes and Cannabinoids in Flower and ExtractMarkus Roggen
This document summarizes a presentation about controlling terpenes and cannabinoids in cannabis flowers and extracts. It discusses how cultivation conditions, drying/curing methods, extraction techniques, and post-processing can influence terpene and cannabinoid levels and ratios. It provides an example of how using THC from different cultivars in a CBD/THC oil caused a patient's seizures to resume, demonstrating the importance of chemovars for medical effects. The presenter advocates for research collaborations to better understand these complex relationships.
Cannabis and Psychedelics – Leanna Standishwwuextendeded
Cannabis and Psychedelics – Leanna Standish, PhD, ND, LAC, FABNO
Presented at the 2015 Palliative Care Summer Institute conference at Bellingham Technical College
Biosimilars are biologic medicines that are similar to already approved biologic reference products, though due to structural complexities they are not generic equivalents. They must demonstrate similarity in terms of safety, purity and potency through comprehensive comparability studies. Biologics are large, complex molecules produced through biotechnology in living cells, whereas generics are identical small molecule chemicals. Due to minor manufacturing differences, biosimilars can have efficacy or immunogenicity issues not seen with generics. India regulates biosimilars through various agencies including the Central Drugs Standard Control Organization.
introduction of Poisoning, types of poison , Poison mechanism of action and their effects, botulism , organophosphorus mushroom, snake venom, introduction of malignant hyperthermia, pathophysiology of it and their mechanism of effects.
002 overview of contribution of natural product in new drug discoverySANDIPLAWARE2
The document provides an overview of the contribution of natural products to new drug discovery. It notes that crude natural product extracts were a major source of early medications and that purified natural products have advantages like standardization of dosage and avoidance of side effects. Many important modern drugs are natural products or derived from them, including antibiotics, antitumor drugs, and the anticancer drug Taxol. While natural products were historically an important source of new drug structures, modern approaches now integrate genomics, biosynthesis, and other fields in the study and development of natural products.
Introduction to biopharmaceutical.pptxssuserda44ff
This document discusses the pharmaceutical biotechnology semester course and provides information on various topics covered. It begins by highlighting how the COVID-19 pandemic has increased focus on the biotechnology field and efforts to develop diagnostics, therapeutics, and vaccines. It then provides an overview of the units to be covered, including pharmaceuticals, biopharmaceuticals, the history of the pharmaceutical industry, and the current and future prospects of biopharmaceuticals.
Cocaine mechanism in human brain & hazard.AhuraCyprian
This is a seminar presented by Chemist Ahura Cyprian at BENUE STATE UNIVERSITY , Makurdi, Nigeria. It centres on the the mechanism of cocaine in human brain and it's health hazards.
The document discusses antimicrobial drugs and antibiotics. It begins by noting that the modern era of antibiotics started with Fleming. It then defines antimicrobial drugs as chemicals that interfere with microbial growth within a host, including antibacterial, antiviral, antiparasitic and antifungal drugs. Antibiotics are natural products produced by bacteria and fungi that kill or inhibit other microorganisms. Antimicrobial drugs are further classified based on their spectrum of action, source, chemical nature and mode of action. The document also discusses mechanisms of action, resistance, and ideal properties of antimicrobial drugs.
Medical Marijuana and Clinical Oncology in 2022"The Good the Bad and the Potentially Ugly"
Marijuana/cannabinoids are particularly appealing for oncology patients offering the possibility of a single medication to encompass a variety of problems, such as pain, nausea, anorexia, sleep disorders , and anxiety.
Dr. Malcolm Brigden - University of Calgary - Canada.
This document discusses the history of cannabis use and research. It notes that cannabis has a long history of medicinal use but was removed from the US Pharmacopoeia in 1942 and classified as a Schedule I drug in 1970 despite evidence that it has medical applications and relatively low risks. Barriers to research have impeded scientific understanding of the endocannabinoid system and cannabis's potential medical benefits.
Week 5 Action potentials, alcohol, and shock therapiesUbaldo Niña
This document summarizes information about action potentials, alcohol, and shock therapies. It discusses how cocaine causes heart attacks, the mechanism of action potentials, and how various substances like alcohol, local anesthetics, and anticonvulsants affect action potentials. It also provides a brief history of shock therapies developed to treat conditions like schizophrenia, including induced seizures, insulin-induced comas, electroconvulsive therapy, and lobotomies.
Poisoning can occur when toxins from plants, mushrooms, or other substances interfere with normal body functions. Nearly 100 plants are toxic to humans. Mushroom poisoning refers to harmful effects from ingesting toxic mushrooms. The most dangerous mushrooms are in the Amanita genus, which contain amatoxins that inhibit RNA polymerase and can cause liver and kidney failure. Proper identification of wild mushrooms is needed to avoid toxic varieties. Treatment focuses on supportive care, decontamination, and use of antidotes like penicillin for Amanita mushroom poisoning.
This document discusses antifungal, antiviral, antimalarial, and antiprotozoal agents. It provides information on:
1) The types of infections each class of agents treats, such as fungal infections, viral infections like HIV and influenza, malaria caused by plasmodium parasites, and protozoal infections including amebiasis and pneumocystis.
2) The mechanisms of action of these agents, such as how polyenes like amphotericin B work by binding to sterols in fungal cell membranes, and how nucleoside analogues like acyclovir inhibit viral DNA synthesis.
3) Important aspects of administering these agents, like monitoring for side
The document discusses the process of developing a molecule into a drug. It begins with choosing a disease and identifying a drug target. Lead compounds are found through screening existing drugs, natural products, combinatorial synthesis or computer-aided design. Lead compounds are then optimized in pre-clinical development through studies of toxicity, pharmacokinetics, and absorption, distribution, metabolism, and excretion. This involves testing in animal and computer models to improve the compound's activity and safety profile before human clinical trials.
Pharmacology of Cholinergic Drugs. It contains a detailed elaboration of Cholinergic Agents, Cholinomimmetics, Cholinergic Antagonists, Synthesis of Ach, Receptors, Classification, Mechanism of Action, Pharmacokinetics and Dynamics, Dosage and Adverse effects
A presentation on Paul Ehrlich developed modern chemotherapy. This was my ppt for the module pharmaceutics 6. It i based on Anti microbial chemo; hope it help others doing relating things.
This document provides an overview of the field of medicinal chemistry. It defines medicinal chemistry as an interdisciplinary research area that incorporates different branches of chemistry and biology to research and develop new drugs. The roles of medicinal chemists include synthesizing and characterizing new compounds, determining biological effects, optimizing lead compounds, and studying pharmacokinetic properties. It also discusses the drug development process and clinical trials. Key aspects covered include drug classification, sources of drug leads, and factors that influence drug properties such as stability and bioavailability.
Medicinal chemistry involves designing and synthesizing pharmaceutical agents to benefit humanity. Key aspects include synthesis, structure-activity relationships, receptor interactions, and absorption, distribution, metabolism, and excretion. The number of new drugs approved each year has declined due to higher standards and focus on complex diseases. Medicinal chemists seek to optimize lead compounds through derivatization while balancing activities, properties, and potential off-target effects to discover safe and effective drugs.
Medicinal chemistry involves designing and synthesizing pharmaceutical agents to benefit humanity. Key aspects include synthesis, structure-activity relationships, receptor interactions, and absorption/metabolism/excretion properties. Natural products have historically provided many drug leads, with plants estimated to provide over 80% of medications in traditional medicine. Medicinal chemists work to optimize drug candidates through systematic modification and evaluation to improve potency, selectivity, and safety profiles.
Total Legal: A “Joint” Journey into the Chemistry of CannabinoidsMarkus Roggen
This lecture gives an overview of the state of the cannabis science, the North American markets and our cannabis research.
Bridging the gap between analytical chemistry, machine learning, and synthetic chemistry, this compilation of studies explores the multifaceted nature of cannabis compounds. We begin with advancements in extraction techniques, utilizing machine learning to optimize yield predictions in large-scale botanical recovery, specifically focusing on cannabis. This approach significantly enhances the efficiency and precision of extraction processes. We then transitions to molecular analysis, examining the stability and transformation of CBD derivatives, highlighting the need for robust quality control in product development. Additionally, the lecture addresses the critical aspect of safety in cannabis use by exploring innovative strategies for heavy metal testing, demonstrating how pooling methods can reduce testing resources while maintaining safety standards. The lecture will answer the question of how to build the best joint, the implications of joint architecture on cannabis consumption, offering insights into optimizing product efficacy and consumer experience.
Overall, this lecture encapsulates the collaborative efforts between academia and innovative research, providing a comprehensive understanding of the complexities and potential of cannabis chemistry.
Unveiling the Cannabis Plant’s PotentialMarkus Roggen
Cannabinoid research is one of the most exciting areas of the cannabis science field, with new information being discovered about the potential therapeutic benefits of cannabinoids on a seemingly frequent basis. As we learn more about the cannabinoids that make up the cannabis plant and their unique qualities, research must be conducted with a focus on applying knowledge toward developing wellness products and cannabis therapies for patients. This panel will discuss the unique challenges facing the cannabinoid research field, results from recent research efforts, and what the future may hold for therapeutic applications of cannabinoids.
Cannabis and Psychedelics – Leanna Standishwwuextendeded
Cannabis and Psychedelics – Leanna Standish, PhD, ND, LAC, FABNO
Presented at the 2015 Palliative Care Summer Institute conference at Bellingham Technical College
Biosimilars are biologic medicines that are similar to already approved biologic reference products, though due to structural complexities they are not generic equivalents. They must demonstrate similarity in terms of safety, purity and potency through comprehensive comparability studies. Biologics are large, complex molecules produced through biotechnology in living cells, whereas generics are identical small molecule chemicals. Due to minor manufacturing differences, biosimilars can have efficacy or immunogenicity issues not seen with generics. India regulates biosimilars through various agencies including the Central Drugs Standard Control Organization.
introduction of Poisoning, types of poison , Poison mechanism of action and their effects, botulism , organophosphorus mushroom, snake venom, introduction of malignant hyperthermia, pathophysiology of it and their mechanism of effects.
002 overview of contribution of natural product in new drug discoverySANDIPLAWARE2
The document provides an overview of the contribution of natural products to new drug discovery. It notes that crude natural product extracts were a major source of early medications and that purified natural products have advantages like standardization of dosage and avoidance of side effects. Many important modern drugs are natural products or derived from them, including antibiotics, antitumor drugs, and the anticancer drug Taxol. While natural products were historically an important source of new drug structures, modern approaches now integrate genomics, biosynthesis, and other fields in the study and development of natural products.
Introduction to biopharmaceutical.pptxssuserda44ff
This document discusses the pharmaceutical biotechnology semester course and provides information on various topics covered. It begins by highlighting how the COVID-19 pandemic has increased focus on the biotechnology field and efforts to develop diagnostics, therapeutics, and vaccines. It then provides an overview of the units to be covered, including pharmaceuticals, biopharmaceuticals, the history of the pharmaceutical industry, and the current and future prospects of biopharmaceuticals.
Cocaine mechanism in human brain & hazard.AhuraCyprian
This is a seminar presented by Chemist Ahura Cyprian at BENUE STATE UNIVERSITY , Makurdi, Nigeria. It centres on the the mechanism of cocaine in human brain and it's health hazards.
The document discusses antimicrobial drugs and antibiotics. It begins by noting that the modern era of antibiotics started with Fleming. It then defines antimicrobial drugs as chemicals that interfere with microbial growth within a host, including antibacterial, antiviral, antiparasitic and antifungal drugs. Antibiotics are natural products produced by bacteria and fungi that kill or inhibit other microorganisms. Antimicrobial drugs are further classified based on their spectrum of action, source, chemical nature and mode of action. The document also discusses mechanisms of action, resistance, and ideal properties of antimicrobial drugs.
Medical Marijuana and Clinical Oncology in 2022"The Good the Bad and the Potentially Ugly"
Marijuana/cannabinoids are particularly appealing for oncology patients offering the possibility of a single medication to encompass a variety of problems, such as pain, nausea, anorexia, sleep disorders , and anxiety.
Dr. Malcolm Brigden - University of Calgary - Canada.
This document discusses the history of cannabis use and research. It notes that cannabis has a long history of medicinal use but was removed from the US Pharmacopoeia in 1942 and classified as a Schedule I drug in 1970 despite evidence that it has medical applications and relatively low risks. Barriers to research have impeded scientific understanding of the endocannabinoid system and cannabis's potential medical benefits.
Week 5 Action potentials, alcohol, and shock therapiesUbaldo Niña
This document summarizes information about action potentials, alcohol, and shock therapies. It discusses how cocaine causes heart attacks, the mechanism of action potentials, and how various substances like alcohol, local anesthetics, and anticonvulsants affect action potentials. It also provides a brief history of shock therapies developed to treat conditions like schizophrenia, including induced seizures, insulin-induced comas, electroconvulsive therapy, and lobotomies.
Poisoning can occur when toxins from plants, mushrooms, or other substances interfere with normal body functions. Nearly 100 plants are toxic to humans. Mushroom poisoning refers to harmful effects from ingesting toxic mushrooms. The most dangerous mushrooms are in the Amanita genus, which contain amatoxins that inhibit RNA polymerase and can cause liver and kidney failure. Proper identification of wild mushrooms is needed to avoid toxic varieties. Treatment focuses on supportive care, decontamination, and use of antidotes like penicillin for Amanita mushroom poisoning.
This document discusses antifungal, antiviral, antimalarial, and antiprotozoal agents. It provides information on:
1) The types of infections each class of agents treats, such as fungal infections, viral infections like HIV and influenza, malaria caused by plasmodium parasites, and protozoal infections including amebiasis and pneumocystis.
2) The mechanisms of action of these agents, such as how polyenes like amphotericin B work by binding to sterols in fungal cell membranes, and how nucleoside analogues like acyclovir inhibit viral DNA synthesis.
3) Important aspects of administering these agents, like monitoring for side
The document discusses the process of developing a molecule into a drug. It begins with choosing a disease and identifying a drug target. Lead compounds are found through screening existing drugs, natural products, combinatorial synthesis or computer-aided design. Lead compounds are then optimized in pre-clinical development through studies of toxicity, pharmacokinetics, and absorption, distribution, metabolism, and excretion. This involves testing in animal and computer models to improve the compound's activity and safety profile before human clinical trials.
Pharmacology of Cholinergic Drugs. It contains a detailed elaboration of Cholinergic Agents, Cholinomimmetics, Cholinergic Antagonists, Synthesis of Ach, Receptors, Classification, Mechanism of Action, Pharmacokinetics and Dynamics, Dosage and Adverse effects
A presentation on Paul Ehrlich developed modern chemotherapy. This was my ppt for the module pharmaceutics 6. It i based on Anti microbial chemo; hope it help others doing relating things.
This document provides an overview of the field of medicinal chemistry. It defines medicinal chemistry as an interdisciplinary research area that incorporates different branches of chemistry and biology to research and develop new drugs. The roles of medicinal chemists include synthesizing and characterizing new compounds, determining biological effects, optimizing lead compounds, and studying pharmacokinetic properties. It also discusses the drug development process and clinical trials. Key aspects covered include drug classification, sources of drug leads, and factors that influence drug properties such as stability and bioavailability.
Medicinal chemistry involves designing and synthesizing pharmaceutical agents to benefit humanity. Key aspects include synthesis, structure-activity relationships, receptor interactions, and absorption, distribution, metabolism, and excretion. The number of new drugs approved each year has declined due to higher standards and focus on complex diseases. Medicinal chemists seek to optimize lead compounds through derivatization while balancing activities, properties, and potential off-target effects to discover safe and effective drugs.
Medicinal chemistry involves designing and synthesizing pharmaceutical agents to benefit humanity. Key aspects include synthesis, structure-activity relationships, receptor interactions, and absorption/metabolism/excretion properties. Natural products have historically provided many drug leads, with plants estimated to provide over 80% of medications in traditional medicine. Medicinal chemists work to optimize drug candidates through systematic modification and evaluation to improve potency, selectivity, and safety profiles.
Total Legal: A “Joint” Journey into the Chemistry of CannabinoidsMarkus Roggen
This lecture gives an overview of the state of the cannabis science, the North American markets and our cannabis research.
Bridging the gap between analytical chemistry, machine learning, and synthetic chemistry, this compilation of studies explores the multifaceted nature of cannabis compounds. We begin with advancements in extraction techniques, utilizing machine learning to optimize yield predictions in large-scale botanical recovery, specifically focusing on cannabis. This approach significantly enhances the efficiency and precision of extraction processes. We then transitions to molecular analysis, examining the stability and transformation of CBD derivatives, highlighting the need for robust quality control in product development. Additionally, the lecture addresses the critical aspect of safety in cannabis use by exploring innovative strategies for heavy metal testing, demonstrating how pooling methods can reduce testing resources while maintaining safety standards. The lecture will answer the question of how to build the best joint, the implications of joint architecture on cannabis consumption, offering insights into optimizing product efficacy and consumer experience.
Overall, this lecture encapsulates the collaborative efforts between academia and innovative research, providing a comprehensive understanding of the complexities and potential of cannabis chemistry.
Unveiling the Cannabis Plant’s PotentialMarkus Roggen
Cannabinoid research is one of the most exciting areas of the cannabis science field, with new information being discovered about the potential therapeutic benefits of cannabinoids on a seemingly frequent basis. As we learn more about the cannabinoids that make up the cannabis plant and their unique qualities, research must be conducted with a focus on applying knowledge toward developing wellness products and cannabis therapies for patients. This panel will discuss the unique challenges facing the cannabinoid research field, results from recent research efforts, and what the future may hold for therapeutic applications of cannabinoids.
Have a Good Trip? How to Analyze PsychedelicsMarkus Roggen
Entheogens, frequently used interchangeably with hallucinogens and psychedelics, are naturally occurring psychoactive substances. Historically, these substances have been used to induce a change of perception, mood, consciousness, or behavior for the purposes of spiritual development or social enrichment. In addition to these uses, these substances have become strong candidates for alternative medicines for the treatment of psychological disorders. Cannabis, a more common entheogen, has paved the way for decriminalization and legalization of other substances, such as psilocin, psilocybin, MDMA, and LSD to be used for clinical treatments. While these compounds in many places are still classified as Schedule I substances under the Controlled Substances Act, other entheogenic plants with different psychoactive compounds are not, such as Mitragyna speciosa and Amanita muscaria, which already appear on the market in the form of edibles, extracts, or powders. With the lack of standardized methods for these psychoactive targets, and with the rise of legalization and clinical treatment centers, it is important to understand this emerging market from a safety and quality perspective. This session will focus on emerging products, testing targets, sample preparation, method development, and analytical challenges. Attendees of this session will learn technical steps that need to be considered to develop robust, reproducible analytical methods, and a quality assurance program to expand into this new and evolving area of testing.
From Leaf to Lab: Uncovering the Molecular Mysteries of CannabisMarkus Roggen
This lecture presents our cannabis research, conducted in collaboration with the University of British Columbia (UBC) Chemistry Department.
Bridging the gap between analytical chemistry, machine learning, and synthetic chemistry, this compilation of studies explores the multifaceted nature of cannabis compounds. We begin with advancements in extraction techniques, utilizing machine learning to optimize yield predictions in large-scale botanical recovery, specifically focusing on cannabis. This approach significantly enhances the efficiency and precision of extraction processes. We then transitions to molecular analysis, examining the stability and transformation of CBD derivatives, highlighting the need for robust quality control in product development. Additionally, the lecture addresses the critical aspect of safety in cannabis use by exploring innovative strategies for heavy metal testing, demonstrating how pooling methods can reduce testing resources while maintaining safety standards. The lecture will answer the question of how to build the best joint, the implications of joint architecture on cannabis consumption, offering insights into optimizing product efficacy and consumer experience.
Overall, this lecture encapsulates the collaborative efforts between academia and innovative research, providing a comprehensive understanding of the complexities and potential of cannabis chemistry.
Your Secret Sauce to Succeeding as a Cannabis Business: A Data-Driven ApproachMarkus Roggen
The cannabis industry is going through boom-bust cycles, many businesses are losing money or barely scrape by. All that is set against an ever-growing market with sales growing 20-30% year over year.
In this session we are analysing various factors exerting pressure on the industry, from taxes to testing costs, but also business strategies and operational decisions. This is all funded on extensive analysis of dataset from sales, business performance, production processes and public sources.
The work from an interdisciplinary team of economists, data scientists and chemists cumulated in an in-depth analysis of the cannabis economy and guiding principles for industry-wide success.
Hot Topics and Hotboxing: Latest research on cannabis aerosolsMarkus Roggen
Cannabis testing focuses on harm reduction, by testing for unwanted pesticides, heavy metals and biological contamination. On one side, cannabinoid levels are precisely measured in the product.
Although these final product tests miss one important aspect of cannabis consumption. The actual process of consumption. For inhalable products, like joints and vape cartridges, the dosing of cannabinoids and chemical changes during burning/vaporization are mostly unknow.
We have developed a testing platform to quantify cannabinoid and terpene levels on a puff per puff basis. This setup also allows us to screen the aerosol and gas phase for potential toxicants present. We also looked at cannabinoid concentrations puff by puff, how those compare between joints and vapes, and how those levels change over the lifecycle of a product.
In this talk we will present our findings from our latest vape and joint experiment and answer the longstanding question: Which part of a joint is the best to smoke? And, will cannabis kill you?
How Long Is Your Trip? Analysing the Micros and Heroics of PsychedelicsMarkus Roggen
Psychedelics are a diverse group of drugs that are known for their ability to alter consciousness, perception, mood, and thought. Detecting the presence, quantity and quality of these compounds is crucial to research development and involves various analytical tools such as High Performance Liquid Chromatography (HPLC) with optical or mass detectors, and other instruments types. These analytical tests are performed for a variety of reasons, including product, drug, or safety testing, all of which are subject to regulations and guidelines set by the licensing authorities. Besides the regulations, we face several other challenges with psychedelic analysis, such as the lack of standardized testing methods, difficulties in sample preparation, and analyte stability.
Birds, Bees and Buds: How to Talk About Cannabis and How to Label it CorrectlyMarkus Roggen
The current labeling of cannabis products is complicated, useless, and even gives the wrong incentive to the customer. The current market is tilted towards buying the highest total THC percentage, because it is a number that everyone believes they understand. There is a lot wrong with this. Starting from the problem that total THC is miscalculated. Adding the fact that “potency” and intoxication are not directly linked. Cannabis offers more bioactive compounds then just THC and CBD, but current labeling doesn’t show it. How can we present a cannabis product in a new way to guide the customer/patent to the right product. This presentation will build on my publications in the area of total THC labeling and chemovar research.
Crystallizing the science of CBD purificationMarkus Roggen
Cannabidiol, or CBD, is the new star of functional ingredients. It is a food, medicine, saviour of the farmers, even a health elixir.
The cannabis and hemp industries have recently experienced extreme growth and progress in all fields. Countries, states and countries are legalizing hemp and/or cannabis, cannabinoid producers see unpreceded business growth, new treatment option for various conditions are researched and approved. But while the markets are growing, hemp and cannabis producers are suffering. An overproduction depresses commodity prices, and inefficient processes squeeze the profit margins. Additionally, hemp and cannabis products require high purity of cannabinoid ingredients, both from a regulatory level and for patient care.
This presentation will cover the latest research on CBD isolation, from its solubility behaviour in common extraction solvents to purification via crystallization. Our latest findings in understanding, controlling, and optimizing cannabis production in analytics, processing, extraction and formulation are presented. The collaborative effort of the multidisciplinary research team at Delic Labs led to a diverse set of insight in every stage of production.
Simulations of Test Reduction Using Pooled Heavy Metals Analysis in CannabisMarkus Roggen
Background: Cannabis species have a propensity to bioaccumulate toxic heavy metals from their growth media. Increased testing for these metals is required to improve the safety of the legal medical and recreational cannabis industries. However, the current methods used for mandated heavy metals tests are not efficient for a large framework. As a result, there is limited testing capacity, high testing costs, and long wait times for results across North America.
Objective: This study aimed to demonstrate that pooling strategies can be used to increase the throughput in cannabis testing labs and reduce some of the strain on the industry.
Methods: This paper presents an algorithm to simulate different pooling strategies. The algorithm was applied to real world data sets collected from Washington and California state testing labs.
Results: Using a single pooling method, for the California lab, pooling four samples on average resulted in a 54.1% reduction in tests required for 100 samples. Conclusion: The algorithms generated from lab data demonstrated that pooled testing strategies can be developed on a case- by-case method to reduce the time, effort, and costs associated with heavy metals tests.
Highlights: The benefits of pooled testing will vary depending on the region and rate of contamination seen in each testing lab. Overall, our results demonstrate pooled testing has the potential to reduce the fiscal costs of testing through increased efficiency, allowing increased testing, leading to greater safety.
Structure Activity Relationship between the Emerging Psychedelic Industry and...Markus Roggen
DELIC Labs seeks to establish a research hub in Vancouver to study cannabis and mushrooms through process design, optimization, analytics, and formulation research. It collaborates with academic and industry partners globally. The document discusses psychedelic compounds and their medical potential but also highlights flaws in current clinical trials, a lack of knowledge about psilocybin mushroom composition, and Delic Labs' work using metabolomics to address this. It also covers the patenting of psilocybin crystal structures and questions whether this is appropriate given the medical applications of these compounds.
- DELIC Labs conducts research on cannabis and mushroom production, collaborating with academic and industry partners. Research topics include process optimization, analytics, and formulation studies.
- CBD usage is increasing globally but users face confusion over legality, regulation, and determining proper dosages. CBD concentrations in e-liquids were found to deviate significantly from labeled amounts in some cases.
- CBD is subject to degradation over time from factors like heat, light, pH levels, and metal leaching. On average, 20% degradation was observed after 30 days at 37°C.
Out of the Shadows: Identifying Impurities in Cannabis ProductsMarkus Roggen
Highly concentrated cannabis products have seen rapid growth, as customers become more accustomed to cannabis consumption and actively seek out high-potency products. Cannabis concentrates come in various forms and product names, from Badder, Budder and Crumble to Distillate, Oil and Shatter. Those products can have THC concentrations are high as 95%, compared with less than 25% common in cannabis flower.
While the actual THC concentration can vary between 70 and 95%, what is common for all cannabis concentrates is that the total of identified compounds seldomly goes above 95% of product weight.
Delic Labs is a research venture that seeks to add fundamental scientific insight to the field of cannabis and mushroom production. In this regard, we set out to identify those compounds in the missing mass balance for cannabis concentrates. This presentation will show our latest advances in characterizing and quantifying impurities in cannabis concentrates. For example, we found reduced cannabinoid species in CBN products, THC isomers in distillates and oxidation products in CBD formulations.
Deep Purple: Discolouration in CBD productsMarkus Roggen
Presentation at ACS Spring 2022 conference.
Recently, there has been a flood of cannabidiol (CBD)-containing products, with divers marketing claims for a plethora of use cases. With this new market segment, regulatory oversight is still developing, and label claims of CBD concentration is often verifiable. CBD is unstable in solution and some CBD products are anecdotally reported to turn purple on storage; however, the decomposition products of CBD are mostly unknown.
Delic Lab embarked on a long and painstaking hunt for those decomposition products, established their identity through complementary chemical methods and established reaction pathways between them.
We will present our findings about common CBD oxidation products, who those are highly photochemically unstable and decomposes rapidly. Decomposition leads to a multitude of new cannabinoid derivatives.
Artificial Intelligence for Craft Cannabis ProductsMarkus Roggen
Cannabis extraction operations focus on extraction yields. This is an imprecise way to think about production. Defining the yield as yield per pound of biomass is very difference to yield per hour. And yield should not be the only focus for extractors. Quality of extract, cost of extraction, loss in post-processing, all these aspects should be considered too.
Our laboratory undertook extensive experimental studies on the extraction behavior of various solvents. We furthermore analyzed thousands of real-world extractions, from various producers and for different instruments to build a machine learning algorithm that can optimize extraction processes autonomously.
We present our latest results and insights from developing and utilizing our extraction optimization AI, to give the audience most actionable insight on how to make better cannabis extracts.
Don’t hold your breath: Smoke and vaping studies on cannabis products to qua...Markus Roggen
Delic Labs is a research company that collaborates with academic and industry partners to study cannabis and mushroom production through process design, optimization, and analytics research. Their research focuses on understanding thermal degradation of cannabinoids and terpenes during smoking and vaping, as well as quantifying cannabinoid and terpene levels inhaled on a puff-by-puff basis to provide insights into real-world usage. The research aims to add fundamental scientific insights to support the cannabis and mushroom industries.
DELIC Labs seeks to add scientific insight to cannabis and mushroom production through collaborative research. Their research focuses on process design, optimization, analytics, and formulation. They collaborate with academic and industry partners. Their research topics include process control, kinetics, in-process analytics, computational studies, and process development. CO2 extraction optimization is limited by focusing on single parameters and empirical exploration. DELIC Labs uses over 100,000 data points from multiple instruments and producers to develop machine learning and Bayesian optimization models to identify optimal extraction conditions considering multiple interactive factors.
Cannabis/Hemp Decarboxylation Monitoring by IRMarkus Roggen
CBDV is a research venture focused on supporting the cannabis and mushroom industries through collaborative research. Some areas of research include process design, optimization, and analytics. CBDV utilizes various analytical techniques like infrared spectroscopy to monitor decarboxylation reactions for cannabis extracts. IR spectroscopy allows for fast, easy, and economical in-process monitoring of decarboxylation without sample preparation. CBDV has developed IR monitoring methods for crude oil and flower and shown IR can predict cannabinoid concentrations during decarboxylation. Computational studies explored rate differences in THCA and CBDA decarboxylation. In summary, CBDV utilizes IR spectroscopy to monitor and control decarboxylation, a key processing step.
1) CBDV is a research venture that seeks to add scientific insight to cannabis and mushroom production through process design, optimization, analytics, and formulation research conducted in collaboration with academic and industry partners.
2) CBDV's research topics include chemometrics, kinetics, in-process analytics, computational studies, and process development for fundamental cannabis and mushroom chemistry.
3) CBDV has expertise in analytical chemistry, process chemistry, engineering, physics, data science, and statistics and is led by Dr. Markus Roggen and Prof. Glenn Sammis to provide scientific insights and solutions for the cannabis and mushroom industries.
When I was asked to give a companion lecture in support of ‘The Philosophy of Science’ (https://shorturl.at/4pUXz) I decided not to walk through the detail of the many methodologies in order of use. Instead, I chose to employ a long standing, and ongoing, scientific development as an exemplar. And so, I chose the ever evolving story of Thermodynamics as a scientific investigation at its best.
Conducted over a period of >200 years, Thermodynamics R&D, and application, benefitted from the highest levels of professionalism, collaboration, and technical thoroughness. New layers of application, methodology, and practice were made possible by the progressive advance of technology. In turn, this has seen measurement and modelling accuracy continually improved at a micro and macro level.
Perhaps most importantly, Thermodynamics rapidly became a primary tool in the advance of applied science/engineering/technology, spanning micro-tech, to aerospace and cosmology. I can think of no better a story to illustrate the breadth of scientific methodologies and applications at their best.
Authoring a personal GPT for your research and practice: How we created the Q...Leonel Morgado
Thematic analysis in qualitative research is a time-consuming and systematic task, typically done using teams. Team members must ground their activities on common understandings of the major concepts underlying the thematic analysis, and define criteria for its development. However, conceptual misunderstandings, equivocations, and lack of adherence to criteria are challenges to the quality and speed of this process. Given the distributed and uncertain nature of this process, we wondered if the tasks in thematic analysis could be supported by readily available artificial intelligence chatbots. Our early efforts point to potential benefits: not just saving time in the coding process but better adherence to criteria and grounding, by increasing triangulation between humans and artificial intelligence. This tutorial will provide a description and demonstration of the process we followed, as two academic researchers, to develop a custom ChatGPT to assist with qualitative coding in the thematic data analysis process of immersive learning accounts in a survey of the academic literature: QUAL-E Immersive Learning Thematic Analysis Helper. In the hands-on time, participants will try out QUAL-E and develop their ideas for their own qualitative coding ChatGPT. Participants that have the paid ChatGPT Plus subscription can create a draft of their assistants. The organizers will provide course materials and slide deck that participants will be able to utilize to continue development of their custom GPT. The paid subscription to ChatGPT Plus is not required to participate in this workshop, just for trying out personal GPTs during it.
ESR spectroscopy in liquid food and beverages.pptxPRIYANKA PATEL
With increasing population, people need to rely on packaged food stuffs. Packaging of food materials requires the preservation of food. There are various methods for the treatment of food to preserve them and irradiation treatment of food is one of them. It is the most common and the most harmless method for the food preservation as it does not alter the necessary micronutrients of food materials. Although irradiated food doesn’t cause any harm to the human health but still the quality assessment of food is required to provide consumers with necessary information about the food. ESR spectroscopy is the most sophisticated way to investigate the quality of the food and the free radicals induced during the processing of the food. ESR spin trapping technique is useful for the detection of highly unstable radicals in the food. The antioxidant capability of liquid food and beverages in mainly performed by spin trapping technique.
Current Ms word generated power point presentation covers major details about the micronuclei test. It's significance and assays to conduct it. It is used to detect the micronuclei formation inside the cells of nearly every multicellular organism. It's formation takes place during chromosomal sepration at metaphase.
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
The cost of acquiring information by natural selectionCarl Bergstrom
This is a short talk that I gave at the Banff International Research Station workshop on Modeling and Theory in Population Biology. The idea is to try to understand how the burden of natural selection relates to the amount of information that selection puts into the genome.
It's based on the first part of this research paper:
The cost of information acquisition by natural selection
Ryan Seamus McGee, Olivia Kosterlitz, Artem Kaznatcheev, Benjamin Kerr, Carl T. Bergstrom
bioRxiv 2022.07.02.498577; doi: https://doi.org/10.1101/2022.07.02.498577
PPT on Direct Seeded Rice presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfSelcen Ozturkcan
Ozturkcan, S., Berndt, A., & Angelakis, A. (2024). Mending clothing to support sustainable fashion. Presented at the 31st Annual Conference by the Consortium for International Marketing Research (CIMaR), 10-13 Jun 2024, University of Gävle, Sweden.
Or: Beyond linear.
Abstract: Equivariant neural networks are neural networks that incorporate symmetries. The nonlinear activation functions in these networks result in interesting nonlinear equivariant maps between simple representations, and motivate the key player of this talk: piecewise linear representation theory.
Disclaimer: No one is perfect, so please mind that there might be mistakes and typos.
dtubbenhauer@gmail.com
Corrected slides: dtubbenhauer.com/talks.html
4. www.outco.com
Molecular structure has a huge effect on how
molecules interact with the human body. Small
changes in stereochemistry, functional groups or
carbon backbone will change the effect.
4
Same but Different
5. www.outco.com
Vanilla
• Second most expensive spice
• Worlds favored flavoring
• 95% of all “vanilla” products use synthetic vanillin
• Real vanilla better for cookies, syn. vanillin for baking
5
Same but Different
Real Fake
Plus hundreds of other compounds
6. www.outco.com
Total Synthesis vs. Semisynthesis
• Taxol is an anticancer drug
isolated from Pacific Yew
• First total synthesis by Holton:
46 linear steps
• Semisynthesis by Holton with
80% yield from European Yew
6
Same but Different
8. www.outco.com
• Heroin acts on opioid receptor
• Relieves pain
• Produces feeling of euphoria
• Highly addictive
• High doses can depress breathing
• Naxloxone reverses effects of opioid overdose
• Has stronger affinity for opioid receptor
• Works within 2 minutes of injection
8
The Opioid Epidemic
9. www.outco.com
• Fentanyl is a synthetic opioid, prescribed by doctors
for chronic pain
• Higher potency increases risk of overdose
9
The Opioid Epidemic
11. www.outco.com
• Professor Emeritus, Organic Chemistry, Clemson
University
• Began in 1984 to synthesis novel cannabinoids
• Focused on targeting endocannabinoid receptors
• For multiple sclerosis, HIV, chemoterapy, …
• Over 450 synthetic cannabinoids developed
• First used as marijuana alternatives in Germany in
late 2000s 11
John William Hoffman
12. www.outco.com
• Professor, Department of Medicinal Chemistry,
Northeastern University
• Study of interactions ‘cannabinoid-like’ molecules
with CB1 & CB2 receptor
• Design and synthesis of novel therapeutically useful
drugs for pain, appetite and central nervous system
diseases
12
Alexandros Makriyannis
13. www.outco.com
• Professor, Department of Medicinal Chemistry,
Hebrew University of Jerusalem
• First to isolate, characterize and synthesis of THC
• Isolated and identified endocannabinoids
• HU-210
• Promotes proliferation, but not differentiation, of
hippocampal neural stem and progenitor cells
• Indication of antianxiety and antidepressant effects
• Implicated in inflammation prevention due to amyloid
beta proteins involved in Alzheimer’s
13
Raphael Mechoulam
14. www.outco.com
• Synthesized in the 1970s and 1980s
• Recently discovered in recreational drugs
• CP 55,940
• Widely used cannabinoid research tool
• Neuroprotective by reducing intracellular calcium
release
14
Pfizer
15. www.outco.com
• Molecules that target CB1 & CB2 receptors
• No precedent in scientific literature
• Appear to be rationally designed
• Little to no information about pharmacology and
toxicology
15
Designer Cannabinoids
16. www.outco.com
• Agonist binds to receptor: Key for the lock
• Full: Copy of key
• Partial: Lock Pick
• Inverse: Opposite effect of normal
• Antagonist blocks others from binding: Putty for lock
16
Terms and Conditions
17. www.outco.com
• THC: Partial agonist to CB1 & CB2
• CBD: Antagonist for CB1 & CB2
• 2-AG: Full agonist for CB1
17
Terms and Conditions
18. www.outco.com
• All claims made are ’soft’
• Didn’t find a drug that is FDA approved
• Most studies are in animal models or in vitro
• Therefore not directly applicable to humans
18
Terms and Conditions
20. www.outco.com
• Full CB agonist
• Potent analgesic (painkiller)
• Prevent inflammation caused by amyloid beta proteins
involved in Alzheimer’s disease
• Prevent cognitive impairment, loss of neuronal markers
• Reduces voluntary wheel running in mice
20
WIN 55,212-2
21. www.outco.com
• Potent CB2 agonist
• 200x more selective for CB2 over CB1
• Not psychoactive as CB2 selective
• Prevent inflammation caused by amyloid beta
proteins involved in Alzheimer’s disease
21
JWH-133
22. www.outco.com
• Prof. Bob Moore II, University of Tenesee
• CB2 inverse agonist
• In pre-clinical development for treatment of
neurodegenerative disorders and traumatic brain
injury
22
SMM-189
doi: 10.1002/prp2.159
24. www.outco.com
• Anti-obesity drug / appetite suppressant
• Inverse agonist for CB1
• Approved in 2006 (EU), first of its class
• Withdrawn in 2008
• Risk of serious psychiatric problems
• 10% experience depressive disorders
• 1% suicidal ideation
• Additionally: nausea, upper respiratory tract infections,
anxiety, insomnia, diarrhea, vomiting, …
24
Rimonabant, Sanofi-Aventis
25. www.outco.com
• Full agonist for CB1 & CB2
• Similar effects to THC, but 5x greater
• Death linked to JWH-018 by drug toxicity and organ
failure
25
JWH-018
27. www.outco.com
• “Unnatural” enantionmer of HU-210
• Not a CB agonist
• NMDA antagonist
• Anesthetic effect like ketamine or synthetic opioids
• No cannabis-like effects
• But anticonvulsant and neuroprotective
• Studied for treating head injury, stroke, or cancer
• Currently in Phase I for treating brain cancer
27
Dexanabinol
28. www.outco.com
• Patented by Mark Scialdone, PhD
• He reports similar ‘High’ as THC
• No further clinical study beyond his own consumption
• He hydrogenated cannabis extract, then consumed it
28
Hydrogenated Cannabinoids